Biosafety risk assessment and risk control of clinical laboratory in designated hospitals for treating COVID-19 in Chongqing, China.
Am J Infect Control
; 50(9): 999-1005, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35671845
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Nucleic Acids
/
COVID-19
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Am J Infect Control
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
United States